Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Sphenopalatine Ganglion Block for Headache After Concussion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on sphenopalatine ganglion block for headache after concussion; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sphenopalatine ganglion block

Snippet

Sponsor: University of Michigan | Conditions: Concussion, Headache | Phase 2 | Status: TERMINATED | Results posted: 2022-05-18